A New Era in
Non-Invasive
Metabolic Sensing

Advanced sensing technology for glucose and hydration monitoring, designed for everyday wearable devices.

Glucose Alert System

Non-invasive indication of rising, high, or stable glucose levels

Hydration Sensing

Advanced hydration sensing to help recognize dehydration and support everyday wellness

GWave is pioneering advanced non-invasive sensing technology designed to transform how glucose and hydration are monitored.

Combining proprietary radio-frequency (RF) sensing technology with advanced machine learning, GWave is developing innovative sensing solutions intended to be integrated into a smartwatch, bringing meaningful metabolic insights into everyday life.

With promising research results, a growing intellectual property portfolio, and an international team of leading scientists and engineers, GWave is advancing toward commercial readiness and strategic licensing opportunities.

Breaking Barriers in Metabolic Health

Making Metabolic Monitoring Accessible, Non-Invasive, and Part of Everyday Life

For decades, glucose monitoring has relied on blood-based testing or sensors that penetrate the skin. While these technologies have transformed diabetes management, they remain invasive and are not designed for the broader population seeking convenient, everyday metabolic insights.

At the same time, understanding hydration status remains a challenge, with limited options for convenient, real-time, non-invasive monitoring.

GWave is redefining what is possible in metabolic health.

Our vision is to transform metabolic monitoring from something people do occasionally, or only when medically necessary, into a natural part of everyday health awareness.

This represents a significant opportunity to expand the reach of metabolic sensing beyond traditional medical applications and into the global consumer health and wellness market.

A Growing Global Need. An Expanding Market Opportunity.

589M

Adults Living With Diabetes Worldwide

According to the International Diabetes Federation, approximately 589 million adults worldwide were living with diabetes in 2024, highlighting the growing global need for more accessible glucose monitoring technologies.

635M

Adults With Impaired Glucose Tolerance

An estimated 635 million adults worldwide have impaired glucose tolerance, demonstrating the enormous population that could benefit from greater metabolic awareness and preventive health solutions.

$6.8T

Global Wellness Economy

The global wellness economy reached approximately $6.8 trillion in 2024, reflecting expanding consumer interest and investment in health, prevention, fitness, and personal well-being.

GWave is positioned at the intersection of these major global trends, bringing together non-invasive sensing, wearable technology, and the growing demand for personalized metabolic health insights.

Sources: International Diabetes Federation (IDF Diabetes Atlas); Global Wellness Institute.

Technology

One Technology Platform. Two Transformative Applications.

Non-Invasive Glucose Sensing

Redefining Glucose Awareness

GWave’s innovative glucose alert system is designed to identify rising or high glucose levels and indicate periods of glucose stability, without needles or invasive procedures.

Our technology is intended to expand access to glucose awareness for individuals with prediabetes and consumers interested in metabolic health, with potential future applications for women with gestational diabetes.

In parallel, GWave is advancing its second proprietary product: a full-range, non-invasive glucose sensing system designed to provide numerical glucose readouts, expanding the applications and commercial opportunities of our technology platform.

Non-Invasive Hydration Sensing

A New Dimension in Personal Health Monitoring

Hydration plays a vital role in physical health, cognitive function, and overall well-being.

GWave’s advanced hydration sensing technology is designed to help recognize dehydration and support everyday wellness.

With applications spanning consumer health, fitness, occupational health, and wearable technology, hydration sensing represents a significant additional commercial opportunity for GWave.

Proprietary Innovation. Global Commercial Potential.

GWave’s sensing platform combines advanced RF technology, innovative sensor engineering, and machine learning to enable non-invasive physiological monitoring.

Designed with integration and scalability in mind, our technology offers opportunities for global consumer electronics companies, smartwatch manufacturers, and healthcare technology providers seeking differentiated sensing capabilities.

Our commercialization strategy focuses on strategic partnerships, technology licensing, and potential intellectual property acquisition.

Research & Clinical Studies

Advancing Non-Invasive Sensing Through Scientific Research

GWave’s technology has been evaluated through successive generations of sensors, supported by scientific research and clinical studies conducted in partnership with leading Israeli research and medical institutions.

Our research program reflects the continued evolution of our sensing technology, combining scientific expertise, sensor engineering, and data-driven analysis.

Our Research Journey

1st Gen
First-Generation Sensors
Sheba Medical Center
GWave’s first-generation sensing technology was evaluated in an early clinical study at Sheba Medical Center. The research examined non-invasive glucose measurements in comparison with established blood glucose reference methods, providing an important foundation for the company’s subsequent sensor development.
2nd Gen
Second-Generation Sensors
Weizmann Institute of Science
GWave’s second-generation sensors were evaluated in a study conducted in partnership with the Weizmann Institute of Science. This research contributed to the continued advancement of GWave’s non-invasive sensing technology.
3rd Gen · Now
Third-Generation Sensors
Weizmann Institute of Science
GWave is currently conducting research with its third-generation sensors in partnership with the Weizmann Institute of Science. This work builds on earlier studies and focuses on advancing sensor performance and GWave’s non-invasive sensing capabilities.
Next
Expanded Hospital-Based Clinical Evaluation
Hospital clinic setting
GWave is preparing for an expanded clinical study using its latest-generation sensing technology. The planned study will evaluate glucose and hydration sensing capabilities across a larger and more diverse patient population, including individuals with Type 1 and Type 2 diabetes.

Scientific Publications

GWave’s research has been featured in scientific publications examining its non-invasive glucose sensing technology.

Sheba Medical Center · 2021

Our Team

Experienced Leadership. Scientific Excellence. Engineering Innovation.

GWave brings together an international team of scientists, engineers, and business leaders advancing proprietary non-invasive glucose and hydration sensing technologies. Our multidisciplinary expertise spans biosensing, RF engineering, electromagnetic simulation, physics, machine learning, software development, and commercialization.

Founders & Executive Leadership

Taire Rubin

Co-Founder & VP of Business Development

Bentzi Gruber

Co-Founder & Head of Technology

Shir Efron

Chief Operating Officer

Yarden Gruber

Chief of Staff

Scientific Leadership

Dr. Tal Marciano

VP Science & Product

Dr. Tal Marciano is a physicist specializing in advanced scientific research, data analysis, and technology development. As GWave’s VP of Science & Product, he leads the company’s scientific strategy, sensor development, and product innovation, overseeing the integration of RF sensing technologies and machine learning to advance non-invasive glucose and hydration monitoring. His work focuses on translating complex scientific research into commercially viable sensing solutions.

Prof. Yang Hao

Head of London Laboratory Professor of Antennas and Electromagnetics, Queen Mary University of London

An internationally recognized scientist specializing in biosensing, antenna technologies, and advanced electromagnetic simulation, bringing extensive expertise in the development and optimization of innovative sensing systems.

Dr. Irl Hirsch

Medical Advisor Professor of Medicine, University of Washington

A world-renowned expert and researcher in diabetes and endocrinology, with extensive experience in glucose monitoring technologies, diabetes management, and clinical research. He brings decades of scientific and clinical expertise to GWave’s research and development initiatives.

Research & Engineering

Yossi Diller

Senior R&D Team Lead

Assaf Leibovitz

Software Engineer

Shimon Shahover

Practical Engineer

London Research Laboratory

Advanced Antenna Engineering & Electromagnetic Innovation

GWave’s London research laboratory, led by Prof. Yang Hao, Professor of Antennas and Electromagnetics at Queen Mary University of London, brings world-class expertise in antenna engineering, electromagnetic simulation, and advanced biosensing technologies.

The London team focuses on the design, development, and optimization of GWave’s proprietary antenna technologies, leveraging advanced electromagnetic modeling and simulation capabilities to continuously enhance our technology and sensor performance.

Working alongside GWave’s research and engineering teams in Israel, the London laboratory plays an integral role in advancing the company’s non-invasive glucose and hydration sensing platform.

Contact

Let’s Talk

Interested in partnerships, technology licensing, or learning more about GWave? Send us a message and our team will get back to you.

A New Era inNon-InvasiveMetabolic Sensing